Skip to main content
. Author manuscript; available in PMC: 2024 May 3.
Published in final edited form as: Circulation. 2024 Feb 26;149(14):e1051–e1065. doi: 10.1161/CIR.0000000000001214
Reviewer Employment Research grant Other research support Speakers’ bureau/honoraria Expert witness Ownership interest Consultant/advisory board Other
Ann Gage Cleveland Clinic Foundation None None Abiomed; Zoll Fellows Course* None None None None
Thomas C. Hanff University of Utah ISHLT/Abiomed (ISHLT Cardiogenic Shock Grant PI)* None None None None None None
Jaime A. Hernandez-Montfort BSWH Health Advanced Heart Disease Program None None Abiomed*; Abbott* None None Abbott*; Abiomed* None
Angela Lowenstern Vanderbilt University None None Edwards Lifesciences* None None None None
Van-Khue Ton Massachusetts General Hospital and Harvard Medical School None None None None None None None
This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $5000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $5000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.
*
Modest.
Significant.